Peptide News and Emerging Research

Follow major peptide studies, market developments, and emerging research explained in clear language.

• Semaglutide in 2026: What the Latest Research Shows

  From cardiovascular benefits to new applications, semaglutide research continues to expand. Here is a summary of the most important findings from the past year.

• The Top 5 Longevity Peptides: What the Research Actually Says

  Longevity peptides are one of the most exciting areas of peptide research. But the hype often outpaces the science. We examine the five most promising compounds and give you an honest assessment of what the evidence actually supports.

• RFK Jr., China, and the Peptide Market: What Is Actually Happening

  HHS Secretary RFK Jr. has signaled a major reversal of the 2023 FDA peptide ban. But the bigger story is where your peptides have been coming from in the meantime — and why that matters.

• Finally, Real Hope: Why Retatrutide Could Be the Weight Loss Breakthrough You've Been Waiting For

  Retatrutide targets three hormones at once — GLP-1, GIP, and glucagon — and Phase 3 trial results show participants lost an average of 16.8% of body weight in just 40 weeks. Here is what the science actually says.